Fig. 4From: Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trialsOutcomes of SLE and LN (A SLEDAI; B IgG level)Back to article page